Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response
- PMID: 32849623
- PMCID: PMC7427491
- DOI: 10.3389/fimmu.2020.01748
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response
Abstract
Elderly individuals are the most susceptible to an aggressive form of coronavirus disease (COVID-19), caused by SARS-CoV-2. The remodeling of immune response that is observed among the elderly could explain, at least in part, the age gradient in lethality of COVID-19. In this review, we will discuss the phenomenon of immunosenescence, which entails changes that occur in both innate and adaptive immunity with aging. Furthermore, we will discuss inflamm-aging, a low-grade inflammatory state triggered by continuous antigenic stimulation, which may ultimately increase all-cause mortality. In general, the elderly are less capable of responding to neo-antigens, because of lower naïve T cell frequency. Furthermore, they have an expansion of memory T cells with a shrinkage of the T cell diversity repertoire. When infected by SARS-CoV-2, young people present with a milder disease as they frequently clear the virus through an efficient adaptive immune response. Indeed, antibody-secreting cells and follicular helper T cells are thought to be effectively activated in young patients that present a favorable prognosis. In contrast, the elderly are more prone to an uncontrolled activation of innate immune response that leads to cytokine release syndrome and tissue damage. The failure to trigger an effective adaptive immune response in combination with a higher pro-inflammatory tonus may explain why the elderly do not appropriately control viral replication and the potential clinical consequences triggered by a cytokine storm, endothelial injury, and disseminated organ injury. Enhancing the efficacy of the adaptive immune response may be an important issue both for infection resolution as well as for the appropriate generation of immunity upon vaccination, while inhibiting inflamm-aging will likely emerge as a potential complementary therapeutic approach in the management of patients with severe COVID-19.
Keywords: COVID-19; SARS-CoV-2; immunopathogenesis; immunosenescence; inflammaging.
Copyright © 2020 Cunha, Perazzio, Azzi, Cravedi and Riella.
Figures
Similar articles
-
Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.J Immunol. 2020 Nov 15;205(10):2566-2575. doi: 10.4049/jimmunol.2000892. Epub 2020 Sep 21. J Immunol. 2020. PMID: 32958687 Review.
-
Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.Rev Med Virol. 2020 Sep;30(5):e2144. doi: 10.1002/rmv.2144. Epub 2020 Jul 15. Rev Med Virol. 2020. PMID: 32671966 Free PMC article. Review.
-
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.Allergy. 2020 Jul;75(7):1564-1581. doi: 10.1111/all.14364. Allergy. 2020. PMID: 32396996 Free PMC article. Review.
-
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.J Immunol. 2020 Nov 1;205(9):2437-2446. doi: 10.4049/jimmunol.2000717. Epub 2020 Sep 2. J Immunol. 2020. PMID: 32878912 Free PMC article.
-
Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.J Transl Med. 2020 May 12;18(1):196. doi: 10.1186/s12967-020-02363-3. J Transl Med. 2020. PMID: 32398026 Free PMC article.
Cited by
-
Predictive biomarkers of mortality in patients with severe COVID-19 hospitalized in intensive care unit.Front Immunol. 2024 Aug 30;15:1416715. doi: 10.3389/fimmu.2024.1416715. eCollection 2024. Front Immunol. 2024. PMID: 39281667 Free PMC article.
-
Nonlinear dynamics of multi-omics profiles during human aging.Nat Aging. 2024 Aug 14. doi: 10.1038/s43587-024-00692-2. Online ahead of print. Nat Aging. 2024. PMID: 39143318
-
Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia.J Transl Med. 2024 Aug 12;22(1):755. doi: 10.1186/s12967-024-05556-2. J Transl Med. 2024. PMID: 39135151 Free PMC article.
-
Expression of a stress-inducible heme oxygenase-1 in NK cells is maintained in the process of human aging.Front Immunol. 2024 Jul 19;15:1398468. doi: 10.3389/fimmu.2024.1398468. eCollection 2024. Front Immunol. 2024. PMID: 39100660 Free PMC article.
-
Diverging patterns in innate immunity against respiratory viruses during a lifetime: lessons from the young and the old.Eur Respir Rev. 2024 Jun 12;33(172):230266. doi: 10.1183/16000617.0266-2023. Print 2024 Apr. Eur Respir Rev. 2024. PMID: 39009407 Free PMC article. Review.
References
-
- NIH Coronavirus (COVID-19). National Institutes of Health; (2020). Available online at: https://www.nih.gov/health-information/coronavirus (accessed April 19, 2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous